Golden Biotechnology Corp.

Welcome visit 4th Floor, Pharma Area, GoldenBiotech Booth S 931.
Golden Biotechnology Corp.,leading pharma in cancer ,oncology and other new drugs . Received Orphan Drug Designations by US FDA for Pancreatic Cancer, AML and HCC and Pancreatic Cancer by EU EMA. Completed Phase II trial of NSCLC Lung Cancer and released brilliant results in 2019 ASCO meeting.Winner of the Advance Queensland - Johnson & Johnson Innovation QuickFire Challenge in Alzheimer's Disease study in 2016. In 2018 , successful unblinding on clinical trial of hyperlipidemia. Welcome visit us at Booth S931 Biotech .Welcome for opportunities in invest and new drug development cooperation.&Pharmaceuticals Area.
1. Golden Biotechnology Corp.'s latest developments and clinical progress of new drug Antroquinonol® in Non-small Cell Lung Cancer(NSCLC), Pancreatic Cancer, Liver Cancer(HCC), Hyperlipidemia, Atopic Dermatitis, Hepatitis B, Alzheimer's disease, Non alcoholic Steatohepatitis(NASH) and AML.

HCT Regenerative Co., Ltd.

HCT Regenerative is an American Association of Tissue Banks (AATB) accredited biomedical company. It is the only Taiwanese biomedical company specialized in biologics, regenerative biomaterials, medial devices based on human tissue. HCT Regenerative is the only AATB accredited company that manufactures amnion related products in Asia.

Insilico Taiwan

Insilico Medicine is an artificial intelligence company headquartered in Hong Kong, with R&D and management resources in the USA, China, Russia, UK, Taiwan, and Korea sourced through hackathons and competitions. The company and its scientists are dedicated to extending human productive longevity and transforming every step of the drug discovery and drug development process through the end-to-end drug discovery pipeline. It specializes in generative adversarial networks, reinforcement learning, transfer learning, and meta-learning technologies. In 2017, NVIDIA selected Insilico Medicine as one of the Top 5 AI companies for its social impact. In 2018, Insilico was named one of the global top 100 AI companies by CB Insights. In 2018 it received the Frost & Sullivan 2018 North American Artificial Intelligence for Aging Research and Drug Development Award. Recently, Insilico Medicine published a paper in Nature Biotechnology, hit found within 46 days, and secured $37 million in series B funding, led by prominent biotechnology and AI investors.

Kevin Steel Corp.

Sanitary Ball Valve
High Purity Ball Valve
ASME BPE Ball Valve
Special Alloy Valve
Sampling Valve
Dis

Maywufa Healthcare Group

Maywufa Corporation:
(1) Consumer Products Divison: MaywufaⓇ is the only brand in the industry being awarded as Taiwan’s Top 100 brands. We specialize in haircare and skincare products, with well-established value chain covering R&D, production, branding and marketing.
(2) Pharmaceutical Division: The pharmaceutical division markets new drugs and innovative medical imaging instruments developed by sister companies PhytoHealth Corp. and AmCad BioMed Corp. We also serve as exclusive selling agent for well-known international pharmaceutical companies.

PhytoHealth Corporation:
PhytoHealth is the first new drug development company listed on Taiwan Stock Exchange. The company’s PG2Ⓡ Lyophilized Injection is the first new prescription drug approved by TFDA and currently the only drug approved for treatment of Cancer-Related Fatigue (CRF).
PhytoHealth’s manufacture plant is TFDA approved PIC/S GMP plant. PhyoHealth received the “National Innovation Award” and “Bio Taipei Gold Award”.

AmCad BioMed Corporation:
AmCad is a medical technology company developing a wide range of breakthrough devices. Incorporating artificial intelligence (AI) and early diagnostic technologies, AmCad has successfully developed a number of first-in-class medical devices with a leading position in the medical imaging industry.
Of the six products in its development pipeline, three have been launched with approvals from the US FDA and CE Mark. The AmCAD-UTⓇ Detection for thyroid cancer has also been approved by the CFDA and launched worldwide including China, Singapore, India, etc.

Broadsound Corporation:
Broadsound Corporation is a medical ultrasound equipment company with specialty in medical ultrasound transducers design and manufacturing. Broadsound’s medical ultrasound transducer is eminent in the industry, which is the only replacement probe certified by US FDA 510(k) and CE 1097. The products have been successfully marketed globally in more than 150 countries. Combining the expertise of AmCad BioMed, we aim to develop AI guided portable ultrasound equipment in the untapped global market.

MEIJI TECHNO CO.,LTD.

We are a Japanese manufaturer of optical microscopes ranging from education, laboratory and research level.
We have launched new digital imaging system and new epi-fluorescent microscope equipped with high intensity LED illumination.

National Health Research Institutes

Innovations and brilliant research results of NHRI, such as: Cell Therapy, Big Data in Bio-medicine, Precision Medicine, Cancer Immunotherapy, Regenerative Medicine, Microbiota, New Drugs, Vaccines , Biotech innovations.

Orient PHARMA Co., Ltd.

OEP Group owned high-end and advanced equipment to fulfill the requirement to produce capsules, tablets and nano-injections as well as can meet the quantity needs from small batch to commercial production. The multi-year experience team provides a full range of collaborative projects and equips with the exclusive technology platform for jointly developing new drugs.

Pharmaessentia Corp.

.

PharmaEssentia Corp.

待補